Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Healthcare Biotechnology Medical Instruments & Supplies
Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the... see more

Recent & Breaking News (TSX:EDT)

Spectral Announces ISS and Glass Lewis Recommendations to Vote in Favour of its up to $18.2 Million Offering

Canada NewsWire July 8, 2014

Spectral Diagnostics announces Proposed Offering of up to $18.2 million

Canada NewsWire June 11, 2014

U.S. FDA Approves Spectral's Amended Protocol for its EUPHRATES Trial

Canada NewsWire June 3, 2014

Spectral announces first quarter, 2014 results

Canada NewsWire May 15, 2014

Spectral Diagnostics provides update on results of annual and special meeting of shareholders

Canada NewsWire May 6, 2014

Spectral Diagnostics Announces Leading Independent Proxy Firms Recommend Spectral Shareholders Vote For Name Change and For Amendment of Warrants

Canada NewsWire April 21, 2014

Spectral Diagnostics (T.SDI) jumps 24% on EUPHRATES trial update

Gaalen Engen April 14, 2014

Spectral Updates Status Of EUPHRATES Trial

Canada NewsWire April 14, 2014

Spectral announces fourth quarter and fiscal 2013 results

Canada NewsWire March 27, 2014

Spectral Diagnostics Provides Clinical Update on the Euphrates Trial

Canada NewsWire March 11, 2014

Spectral Diagnostics Announces Extension of Warrants

Canada NewsWire February 24, 2014

Spectral announces status of second interim analysis

Canada NewsWire January 28, 2014

Spectral Announces Third Quarter 2013 Results

Canada NewsWire November 13, 2013

Spectral Reaches Enrollment Milestone for its Phase III Euphrates Trial

Canada NewsWire September 26, 2013

Spectral announces second quarter 2013 results

Canada NewsWire August 13, 2013

Spectral to present at Wedbush Life Sciences Conference

Canada NewsWire August 1, 2013

Spectral provides update on its EUPHRATES trial

Canada NewsWire July 31, 2013

Spectral Diagnostics Announces Board Changes

Canada NewsWire July 26, 2013

Spectral Diagnostics provides update on results of annual and special meeting

Canada NewsWire May 23, 2013

Spectral announces first quarter 2013 results

Canada NewsWire May 15, 2013